News

AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) IN PSORIATIC ARTHRITIS AT EULAR 2023

by

MOSAIC Study is First to use MRI to Assess Inflammation in Peripheral Joints and Entheses in Psoriatic Arthritis Patients Exploratory Analysis Examines Effects of Otezla on Cardiometabolic Parameters THOUSAND OAKS, Calif., May 30, 2023 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced new research examining the use of Otezla® (apremilast) in psoriatic arthritis, including the Phase 4 MOSAIC … Read more

Boston Scientific Announces Conversion Date of Series A Mandatory Convertible Preferred Stock

by

MARLBOROUGH, Mass., May 30, 2023 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) announced today that its Series A 5.50% Mandatory Convertible Preferred Stock (the preferred stock) will automatically convert into shares of the company’s common stock on June 1, 2023. As previously disclosed, holders of record at the close of business on May 15, 2023 … Read more

Sacred Heart Preparatory Graduates Its 125th Class

by

Graduates are headed to colleges across the country and internationally ATHERTON, Calif., May 30, 2023 /PRNewswire/ — Sacred Heart Preparatory (SHP) graduated 171 students at its 125th commencement ceremony on Friday, May 26, its largest graduating class to date. Graduates from the Class of 2023 will attend 84 different institutions: 72 students will study in … Read more

CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of Stockholders

by

SEATTLE, May 30, 2023 /PRNewswire/ — CTI BioPharma Corp. (Nasdaq: CTIC) (“CTI”), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced that it has cancelled the 2023 Annual Meeting of Stockholders (the “Annual Meeting”) which was scheduled for June 21, 2023, and has withdrawn the … Read more

Aurora Technology Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q

by

—Quarterly Report on Form 10-Q and Plan of Compliance Have Now Been Submitted to Nasdaq— SAN FRANCISCO, May 30, 2023 /PRNewswire/ — Aurora Technology Acquisition Corp. (NASDAQ: ATAKU, ATAK, ATAKW, ATAKR) (the “Company”) announced that it had previously received written notification (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) on May … Read more

Phanes Therapeutics announces the appointment of Rita Laeufle, MD, PhD, as Chief Medical Officer

by

SAN DIEGO, May 30, 2023 /PRNewswire/ — Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, today announced that it has appointed Rita Laeufle, MD, PhD, as Chief Medical Officer, effective June 1, 2023. Dr. Laeufle has more than 18 years of experience in clinical development … Read more

Featuring Ion Beam Applications, Siemens Healthineers, Accuray, Elekta, ViewRay & Hitachi

by

DUBLIN, May 30, 2023 /PRNewswire/ — The “Global Radiation Therapy Market with Focus on LINAC: Insights & Forecast with Potential Impact of COVID-19 (2023-2027)” report has been added to  ResearchAndMarkets.com’s offering. The global radiation therapy market is expected to reach US$13.28 billion in 2027, witnessing growth at a CAGR of 6.77%, over the period 2023-2027. … Read more

Hoag Becomes First Hospital on West Coast to Offer Revolutionary 3D Photographic Imaging Technology to Detect and Prevent Skin Cancer and Melanoma

by

Hoag’s Melanoma & Skin Cancer Program Provides Patients Access to the Latest Diagnostic Modalities NEWPORT BEACH, Calif., May 30, 2023 /PRNewswire/ — Hoag is the first hospital on the West Coast to offer high-risk skin cancer patients access to the VECTRA WB360, the world’s first whole-body 3D photographic imaging system, as part of its comprehensive … Read more